Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article

Advertisement

ResearchIn-Press PreviewCOVID-19Immunology Free access | 10.1172/JCI144734

Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity

Sara Falck-Jones,1 Sindhu Vangeti,1 Meng Yu,1 Ryan Falck-Jones,3 Alberto Cagigi,1 Isabella Badolati,1 Björn Österberg,1 Maximilian Julius Lautenbach,4 Eric Ahlberg,1 Ang Lin,1 Rico Lepzien,1 Inga Szurgot,1 Klara Lenart,1 Fredrika Hellgren,1 Holden T. Maecker,5 Jörgen Sälde,6 Jan Albert,7 Niclas Johansson,8 Max Bell,9 Karin Lore,1 Anna Färnert,8 and Anna Smed-Sörensen1

1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden

2Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

3Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden

4Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Insitutet, Solna, Sweden

5Microbiology & Immunology, Stanford University School of Medicine, Stanford, United States of America

6Health Care Services Stockholm County, Stockholm, Sweden

7Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

8Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

9Department of Physiology and Pharmacology, Karolinska Insitutet, Solna, Sweden

10Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Kenya

Find articles by Falck-Jones, S. in: JCI | PubMed | Google Scholar |

1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden

2Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

3Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden

4Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Insitutet, Solna, Sweden

5Microbiology & Immunology, Stanford University School of Medicine, Stanford, United States of America

6Health Care Services Stockholm County, Stockholm, Sweden

7Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

8Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

9Department of Physiology and Pharmacology, Karolinska Insitutet, Solna, Sweden

10Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Kenya

Find articles by Vangeti, S. in: JCI | PubMed | Google Scholar |

1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden

2Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

3Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden

4Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Insitutet, Solna, Sweden

5Microbiology & Immunology, Stanford University School of Medicine, Stanford, United States of America

6Health Care Services Stockholm County, Stockholm, Sweden

7Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

8Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

9Department of Physiology and Pharmacology, Karolinska Insitutet, Solna, Sweden

10Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Kenya

Find articles by Yu, M. in: JCI | PubMed | Google Scholar

1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden

2Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

3Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden

4Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Insitutet, Solna, Sweden

5Microbiology & Immunology, Stanford University School of Medicine, Stanford, United States of America

6Health Care Services Stockholm County, Stockholm, Sweden

7Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

8Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

9Department of Physiology and Pharmacology, Karolinska Insitutet, Solna, Sweden

10Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Kenya

Find articles by Falck-Jones, R. in: JCI | PubMed | Google Scholar |

1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden

2Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

3Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden

4Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Insitutet, Solna, Sweden

5Microbiology & Immunology, Stanford University School of Medicine, Stanford, United States of America

6Health Care Services Stockholm County, Stockholm, Sweden

7Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

8Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

9Department of Physiology and Pharmacology, Karolinska Insitutet, Solna, Sweden

10Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Kenya

Find articles by Cagigi, A. in: JCI | PubMed | Google Scholar

1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden

2Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

3Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden

4Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Insitutet, Solna, Sweden

5Microbiology & Immunology, Stanford University School of Medicine, Stanford, United States of America

6Health Care Services Stockholm County, Stockholm, Sweden

7Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

8Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

9Department of Physiology and Pharmacology, Karolinska Insitutet, Solna, Sweden

10Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Kenya

Find articles by Badolati, I. in: JCI | PubMed | Google Scholar |

1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden

2Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

3Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden

4Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Insitutet, Solna, Sweden

5Microbiology & Immunology, Stanford University School of Medicine, Stanford, United States of America

6Health Care Services Stockholm County, Stockholm, Sweden

7Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

8Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

9Department of Physiology and Pharmacology, Karolinska Insitutet, Solna, Sweden

10Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Kenya

Find articles by Österberg, B. in: JCI | PubMed | Google Scholar

1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden

2Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

3Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden

4Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Insitutet, Solna, Sweden

5Microbiology & Immunology, Stanford University School of Medicine, Stanford, United States of America

6Health Care Services Stockholm County, Stockholm, Sweden

7Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

8Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

9Department of Physiology and Pharmacology, Karolinska Insitutet, Solna, Sweden

10Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Kenya

Find articles by Lautenbach, M. in: JCI | PubMed | Google Scholar

1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden

2Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

3Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden

4Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Insitutet, Solna, Sweden

5Microbiology & Immunology, Stanford University School of Medicine, Stanford, United States of America

6Health Care Services Stockholm County, Stockholm, Sweden

7Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

8Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

9Department of Physiology and Pharmacology, Karolinska Insitutet, Solna, Sweden

10Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Kenya

Find articles by Ahlberg, E. in: JCI | PubMed | Google Scholar

1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden

2Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

3Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden

4Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Insitutet, Solna, Sweden

5Microbiology & Immunology, Stanford University School of Medicine, Stanford, United States of America

6Health Care Services Stockholm County, Stockholm, Sweden

7Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

8Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

9Department of Physiology and Pharmacology, Karolinska Insitutet, Solna, Sweden

10Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Kenya

Find articles by Lin, A. in: JCI | PubMed | Google Scholar |

1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden

2Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

3Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden

4Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Insitutet, Solna, Sweden

5Microbiology & Immunology, Stanford University School of Medicine, Stanford, United States of America

6Health Care Services Stockholm County, Stockholm, Sweden

7Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

8Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

9Department of Physiology and Pharmacology, Karolinska Insitutet, Solna, Sweden

10Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Kenya

Find articles by Lepzien, R. in: JCI | PubMed | Google Scholar |

1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden

2Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

3Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden

4Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Insitutet, Solna, Sweden

5Microbiology & Immunology, Stanford University School of Medicine, Stanford, United States of America

6Health Care Services Stockholm County, Stockholm, Sweden

7Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

8Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

9Department of Physiology and Pharmacology, Karolinska Insitutet, Solna, Sweden

10Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Kenya

Find articles by Szurgot, I. in: JCI | PubMed | Google Scholar

1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden

2Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

3Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden

4Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Insitutet, Solna, Sweden

5Microbiology & Immunology, Stanford University School of Medicine, Stanford, United States of America

6Health Care Services Stockholm County, Stockholm, Sweden

7Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

8Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

9Department of Physiology and Pharmacology, Karolinska Insitutet, Solna, Sweden

10Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Kenya

Find articles by Lenart, K. in: JCI | PubMed | Google Scholar |

1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden

2Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

3Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden

4Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Insitutet, Solna, Sweden

5Microbiology & Immunology, Stanford University School of Medicine, Stanford, United States of America

6Health Care Services Stockholm County, Stockholm, Sweden

7Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

8Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

9Department of Physiology and Pharmacology, Karolinska Insitutet, Solna, Sweden

10Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Kenya

Find articles by Hellgren, F. in: JCI | PubMed | Google Scholar

1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden

2Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

3Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden

4Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Insitutet, Solna, Sweden

5Microbiology & Immunology, Stanford University School of Medicine, Stanford, United States of America

6Health Care Services Stockholm County, Stockholm, Sweden

7Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

8Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

9Department of Physiology and Pharmacology, Karolinska Insitutet, Solna, Sweden

10Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Kenya

Find articles by Maecker, H. in: JCI | PubMed | Google Scholar |

1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden

2Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

3Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden

4Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Insitutet, Solna, Sweden

5Microbiology & Immunology, Stanford University School of Medicine, Stanford, United States of America

6Health Care Services Stockholm County, Stockholm, Sweden

7Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

8Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

9Department of Physiology and Pharmacology, Karolinska Insitutet, Solna, Sweden

10Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Kenya

Find articles by Sälde, J. in: JCI | PubMed | Google Scholar

1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden

2Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

3Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden

4Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Insitutet, Solna, Sweden

5Microbiology & Immunology, Stanford University School of Medicine, Stanford, United States of America

6Health Care Services Stockholm County, Stockholm, Sweden

7Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

8Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

9Department of Physiology and Pharmacology, Karolinska Insitutet, Solna, Sweden

10Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Kenya

Find articles by Albert, J. in: JCI | PubMed | Google Scholar |

1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden

2Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

3Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden

4Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Insitutet, Solna, Sweden

5Microbiology & Immunology, Stanford University School of Medicine, Stanford, United States of America

6Health Care Services Stockholm County, Stockholm, Sweden

7Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

8Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

9Department of Physiology and Pharmacology, Karolinska Insitutet, Solna, Sweden

10Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Kenya

Find articles by Johansson, N. in: JCI | PubMed | Google Scholar

1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden

2Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

3Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden

4Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Insitutet, Solna, Sweden

5Microbiology & Immunology, Stanford University School of Medicine, Stanford, United States of America

6Health Care Services Stockholm County, Stockholm, Sweden

7Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

8Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

9Department of Physiology and Pharmacology, Karolinska Insitutet, Solna, Sweden

10Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Kenya

Find articles by Bell, M. in: JCI | PubMed | Google Scholar |

1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden

2Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

3Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden

4Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Insitutet, Solna, Sweden

5Microbiology & Immunology, Stanford University School of Medicine, Stanford, United States of America

6Health Care Services Stockholm County, Stockholm, Sweden

7Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

8Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

9Department of Physiology and Pharmacology, Karolinska Insitutet, Solna, Sweden

10Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Kenya

Find articles by Lore, K. in: JCI | PubMed | Google Scholar |

1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden

2Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

3Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden

4Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Insitutet, Solna, Sweden

5Microbiology & Immunology, Stanford University School of Medicine, Stanford, United States of America

6Health Care Services Stockholm County, Stockholm, Sweden

7Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

8Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

9Department of Physiology and Pharmacology, Karolinska Insitutet, Solna, Sweden

10Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Kenya

Find articles by Färnert, A. in: JCI | PubMed | Google Scholar |

1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden

2Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

3Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden

4Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Insitutet, Solna, Sweden

5Microbiology & Immunology, Stanford University School of Medicine, Stanford, United States of America

6Health Care Services Stockholm County, Stockholm, Sweden

7Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

8Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

9Department of Physiology and Pharmacology, Karolinska Insitutet, Solna, Sweden

10Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Kenya

Find articles by Smed-Sörensen, A. in: JCI | PubMed | Google Scholar

Published January 25, 2021 - More info

J Clin Invest. https://doi.org/10.1172/JCI144734.
Copyright © 2021, American Society for Clinical Investigation
Published January 25, 2021 - Version history
View PDF
Abstract

The immunopathology of COVID-19 remains enigmatic, exhibiting immunodysregulation and T cell lymphopenia. Monocytic myeloid-derived suppressor cells (M-MDSC) are T cell suppressors that expand in inflammatory conditions, but their role in acute respiratory infections remains unclear. We studied blood and airways of COVID-19 patients across disease severity at multiple timepoints. M-MDSC frequencies were elevated in blood but not in nasopharyngeal or endotracheal aspirates of COVID-19 patients compared to controls. M-MDSCs isolated from COVID-19 patients suppressed T cell proliferation and IFNg production partly via an arginase-1 (Arg-1) dependent mechanism. Furthermore, patients showed increased Arg-1 and IL-6 plasma levels. COVID-19 patients had fewer T cells, and displayed downregulated expression of the CD3ζ chain. Ordinal regression showed that early M-MDSC frequency predicted subsequent disease severity. In conclusion, M-MDSCs expand in blood of COVID-19 patients, suppress T cells and strongly associate with disease severity, suggesting a role for M-MDSCs in the dysregulated COVID-19 immune response.

Graphical Abstract
graphical abstract
Supplemental material

View

Version history
  • Version 1 (January 25, 2021): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts